Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet treatment for treating HIV infection. This drug combines three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the the viral ability to replicate within the body, considerably lowering the viral quantit